172
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Renoprotection by Inhibiting Connexin 43 Expression in a Mouse Model of Obesity-Related Renal Injury

, , , , &
Pages 1415-1424 | Received 28 Mar 2023, Accepted 02 May 2023, Published online: 17 May 2023

References

  • Gunta SS, Mak RH. Is obesity a risk factor for chronic kidney disease in children? Pediatr Nephrol. 2013;28(10):1949–1956. doi:10.1007/s00467-012-2353-z
  • Savino A, Pelliccia P, Giannini C, et al. Implications for kidney disease in obese children and adolescents. Pediatr Nephrol. 2011;26(5):749–758. doi:10.1007/s00467-010-1659-y
  • Fowler SM, Kon V, Ma L, Richards WO, Fogo AB, Hunley TE. Obesity-related focal and segmental glomerulosclerosis: normalization of proteinuria in an adolescent after bariatric surgery. Pediatr Nephrol. 2009;24(4):851–855. doi:10.1007/s00467-008-1024-6
  • Chen HM, Liu ZH, Zeng CH, Li SJ, Wang QW, Li LS. Podocyte lesions in patients with obesity-related glomerulopathy. Am J Kidney Dis. 2006;48(5):772–779. doi:10.1053/j.ajkd.2006.07.025
  • Patrakka J, Tryggvason K. New insights into the role of podocytes in proteinuria. Nat Rev Nephrol. 2009;5(8):463–468. doi:10.1038/nrneph.2009.108
  • Kar R, Batra N, Riquelme MA, Jiang JX. Biological role of connexin intercellular channels and hemichannels. Arch Biochem Biophys. 2012;524(1):2–15. doi:10.1016/j.abb.2012.03.008
  • Abed AB, Kavvadas P, Chadjichristos CE. Functional roles of connexins and pannexins in the kidney. Cell Mol Life Sci. 2015;72(15):2869–2877. doi:10.1007/s00018-015-1964-5
  • Hanner F, Sorensen CM, Holstein-Rathlou NH, Peti-Peterdi J. Connexins and the kidney. Am J Physiol Regul Integr Comp Physiol. 2010;298(5):R1143–1155. doi:10.1152/ajpregu.00808.2009
  • Hillis GS, Duthie LA, Brown PA, Simpson JG, MacLeod AM, Haites NE. Upregulation and co-localization of connexin43 and cellular adhesion molecules in inflammatory renal disease. J Pathol. 1997;182(4):373–379. doi:10.1002/(SICI)1096-9896(199708)182:4<373::AID-PATH858>3.0.CO;2-B
  • Toubas J, Beck S, Pageaud AL, et al. Alteration of connexin expression is an early signal for chronic kidney disease. Am J Physiol Renal Physiol. 2011;301(1):F24–32.
  • Zhao Y, Li G, Wang Y, Liu Z. Alteration of Connexin43 expression in a rat model of obesity-related glomerulopathy. Exp Mol Pathol. 2018;104(1):12–18. doi:10.1016/j.yexmp.2017.11.017
  • Huang Y, Mao Z, Zhang Z, et al. Connexin43 contributes to inflammasome activation and lipopolysaccharide-initiated acute renal injury via modulation of intracellular oxidative status. Antioxid Redox Signal. 2019;31(16):1194–1212. doi:10.1089/ars.2018.7636
  • D’Agati VD, Chagnac A, de Vries AP, et al. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol. 2016;12(8):453–471. doi:10.1038/nrneph.2016.75
  • Luo M, Luo P, Zhang Z, et al. Zinc delays the progression of obesity-related glomerulopathy in mice via down-regulating P38 MAPK-mediated inflammation. Obesity. 2016;24(6):1244–1256. doi:10.1002/oby.21463
  • Sun YB, Qu X, Howard V, et al. Smad3 deficiency protects mice from obesity-induced podocyte injury that precedes insulin resistance. Kidney Int. 2015;88(2):286–298. doi:10.1038/ki.2015.121
  • Yan Z, Ni Y, Wang P, et al. Peroxisome proliferator-activated receptor delta protects against obesity-related glomerulopathy through the P38 MAPK pathway. Obesity. 2013;21(3):538–545. doi:10.1002/oby.20103
  • Marshall CB, Krofft RD, Pippin JW, Shankland SJ. CDK inhibitor p21 is prosurvival in Adriamycin-induced podocyte injury, in vitro and in vivo. Am J Physiol Renal Physiol. 2010;298(5):F1140–1151. doi:10.1152/ajprenal.00216.2009
  • Shankland SJ. The podocyte’s response to injury: role in proteinuria and glomerulosclerosis. Kidney Int. 2006;69(12):2131–2147. doi:10.1038/sj.ki.5000410
  • Koka S, Xia M, Zhang C, Zhang Y, Li PL, Boini KM. Podocyte NLRP3 inflammasome activation and formation by adipokine visfatin. Cell Physiol Biochem. 2019;53(2):355–365.
  • Abed A, Toubas J, Kavvadas P, et al. Targeting connexin 43 protects against the progression of experimental chronic kidney disease in mice. Kidney Int. 2014;86(4):768–779. doi:10.1038/ki.2014.108
  • Kavvadas P, Abed A, Poulain C, et al. Decreased expression of connexin 43 blunts the progression of experimental GN. J Am Soc Nephrol. 2017;28(10):2915–2930. doi:10.1681/ASN.2016111211
  • Yang M, Wang B, Li M, Jiang B. Connexin 43 is involved in aldosterone-induced podocyte injury. Cell Physiol Biochem. 2014;34(5):1652–1662. doi:10.1159/000366367
  • Wang X, Chen H, Zhang M, Liu Z. Roles of mast cells and monocyte chemoattractant protein-1 in the renal injury of obesity-related glomerulopathy. Am J Med Sci. 2013;346(4):295–301. doi:10.1097/MAJ.0b013e31827559f8